Optometrist · Atlanta, GA
NPI
1831380609
Since 2007
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
550 Peachtree St NE, Ste. 1500
Atlanta, GA, 30308
Phone (404) 897-6810
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
551 services
Medicare patients, 2024
222
Average age 74
Drug cost, 2024
$669K
1,425 prescriptions
Company payments, 2025
$530
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Liana M Lynskey was code 92014 (ophthalmological e&m), 149 times for 149 patients. In total Liana M Lynskey billed 551 services in 18 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 149 | 149 | $81.79 | $12K |
| 92133 Computerized Ophthalmic Imaging | Office | 91 | 90 | $26.02 | $2,368 |
| 92083 Vision, Hearing, and Speech Services | Office | 70 | 70 | $47.48 | $3,324 |
| 99213 Office E&M - Established | Office | 67 | 56 | $60.75 | $4,070 |
| 99214 Office E&M - Established | Office | 60 | 54 | $90.63 | $5,438 |
| 92134 Computerized Ophthalmic Imaging | Office | 53 | 44 | $29.20 | $1,548 |
| 68761 Eye | Office | 26 | 15 | $104.10 | $2,707 |
| 92004 Ophthalmological E&M | Office | 13 | 13 | $61.91 | $805 |
By year: 2022 $52K for 851 services; 2023 $32K for 535 services; 2024 $34K for 551 services.
Medicare prescription drug claims, 2024
In 2024, the drug Liana M Lynskey prescribed most often to Medicare patients was Latanoprost, with 184 prescriptions and refills. In total Liana M Lynskey wrote 1,425 Medicare prescriptions that cost $669K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 184 | 463 | 69 | $2,690 |
| Lumigan Bimatoprost | 166 | 318 | 51 | $86K |
| Restasis Cyclosporine | 132 | 283 | 62 | $172K |
| Timolol Maleate Generic | 93 | 237 | 32 | $1,112 |
| Restasis Multidose Cyclosporine | 91 | 197 | 33 | $122K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 76 | 80 | 53 | $671 |
| Tyrvaya Varenicline Tartrate | 55 | 59 | 22 | $36K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 48 | 115 | 21 | $630 |
| Vyzulta Latanoprostene Bunod | 48 | 104 | 16 | $28K |
| Xiidra Lifitegrast | 47 | 103 | 29 | $71K |
| Cyclosporine Generic | 39 | 83 | 19 | $30K |
| Lotemax Sm Loteprednol Etabonate | 34 | 41 | 21 | $8,565 |
| Rhopressa Netarsudil Mesylate | 27 | 50 | 13 | $16K |
| Moxifloxacin Moxifloxacin Hcl | 27 | 27 | 13 | $517 |
| Prednisolone Acetate Generic | 27 | 43 | 22 | $1,458 |
Brand drugs: 895 claims; generic drugs: 530 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Liana M Lynskey $530 ($530 in general payments such as food, travel and fees) from 9 companies. The largest payer was Biotissue Holdings Inc. with $146.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.